Here is how that works, and why it matters
However, patients with type 2 diabetes mellitus tend to lose less weight than those who are non-diabetic
Reconstitute only what you can use within the stability window, or plan to aliquot and freeze the excess immediately
There is significant evidence that people with type 2 diabetes in the US, UK and worldwide do not intensify treatment, despite not achieving glycemic control targets, with concerns around potential side effects of therapies (such as weight gain and hypoglycemia) and fear of injection often cited as reasons for therapeutic inertia [18,19,20,21,22]
77 Coverage tends to be better when these active ingredients are prescribed under their diabetes brand names (Ozempic, Mounjaro) for type 2 diabetes 77 , but this guide focuses on the Wegovy-to-Zepbound switch for weight management
Nelva K